NOV 5, 2026 · REVIEW
Synthetic mRNA engineering beyond prophylactic infectious disease vaccines: epigenomic and molecular reprogramming of diseased cells
Epigenomics
The clinical validation of mRNA-based COVID-19 vaccines in 2020-2021 accelerated the development of synthetic messenger RNA as a precision therapeutic platform beyond infectious di